The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 701–800 of 946
Hurwitz, L. M., Townsend, M. K., Jordan, S. J., Patel, A. V., Teras, L. R., Lacey, J. V., Doherty, J. A., Harris, H. R., Goodman, M. T., Shvetsov, Y. B., et al. (2022) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001096 · Cited by 2
Self-citationGao, Y., Ding, W. Y., & Qu, P. (2023) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5004071 · Cited by 2
Collin, L. J., Cushing‐Haugen, K. L., Terry, K. L., Goode, E. L., Wu, A. H., Harris, H. R., Sasamoto, N., Cramer, D. W., Modugno, F., Elishaev, E., et al. (2025) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-24-1143 · Cited by 2
Self-citationWu, X., Yu, X., Lu, Y., Xie, A., Su, Y., Zhang, L., Lin, Y., & Gan, X. (2025) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s527221 · Cited by 2
Multiple Synchronous Primary Gynecologic Malignancies in an MSH2 Mutation Carrier With Endometriosis
Shoni, M., Parra‐Herran, C., May, T., Wright, A. A., & Feltmate, C. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4274 · Cited by 2
Learning from disease heterogeneity
Gaudet, M. M., Sherman, M. E., & Thun, M. J. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70365-0 · Cited by 2
Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk
Anton, A., Schott, S., Kaip, G., Rath, M., Heil, J., Aulmann, S., & Sinn, H. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3062-y · Cited by 2
The role of stem cells in the pathogenesis of endometriosis (а review)
Farkhat, K. N., Савилова, А. М., Makiyan, Z., & Adamyan, L. V. (2016) · Russian Journal of Human Reproduction · doi:10.17116/repro201622120-27 · Cited by 2
Diagnostic and treatment of endometriosis - recommendations for clinical practice
Spremović-Radjenović, S., Bila, J. S., Vidakovic, S., & Radunović, N. V. (2017) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh160404019s · Cited by 2
Cuarto Consenso Nacional de Cáncer de Ovario
Gallardo‐Rincón, D., Ruvalcaba-Limón, E., Silva-García, A., Aranda-Flores, C. E., Quijano-Castro, O. F., Bañuelos-Flores, J., Montalvo‐Esquivel, G., Pérez-Quintanilla, M., Bahena-González, A., Alamilla-García, G., et al. (2018) · Gaceta Mexicana de Oncología · doi:10.24875/j.gamo.m18000155 · Cited by 2
Morgan, M. A., Boyd, J. A., Drapkin, R., & Seiden, M. V. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00089-8 · Cited by 2
Heidarpour, M., Hoseini-Beheshti, M.-S., & Derakhshan, M. (2020) · Immunopathologia Persa · doi:10.34172/ipp.2020.23 · Cited by 2
Endometriosis and subfertility
Zuberi, N. F., & Rehman, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-75945-8.00008-6 · Cited by 2
Endometriosis and Cancer: Prevention and Diagnosis
Vannuccini, S., Clemenza, S., & Petraglia, F. (2020) · ISGE series · doi:10.1007/978-3-030-57866-4_13 · Cited by 2
Saavalainen, L., Lassus, H. J., But, A., Gissler, M., Heikinheimo, O., & Pukkala, . (2021) · PLoS ONE · doi:10.1371/journal.pone.0253270 · Cited by 2
Endometriose e sua relação com o câncer de ovário: uma revisão integrativa
Alves, T. S., Alves, T. S., de Queiroz, I. C. C. F., Ferreira, S. M., Perez, J. O., Júnior, P. A. R., Drummond, H. P. A., & Abdalla, D. R. (2021) · Research Society and Development · doi:10.33448/rsd-v10i13.20965 · Cited by 2
Epithelial Tumors of the Ovary
Seidman, J. D., Ronnett, B. M., Shih, I., Cho, K. R., & Kurman, R. J. (2018) · Springer eBooks · doi:10.1007/978-1-4614-3165-7_14-2 · Cited by 2
Ovarialkarzinom und Präkanzerosen
van Mackelenbergh, M., Maass, N., Jonat, W., & Hilpert, F. (2015) · Der Gynäkologe · doi:10.1007/s00129-015-3720-1 · Cited by 2
Chirurgie annexielle prophylactique des femmes à risque héréditaire : vers de nouvelles pistes ?
Leblanc, É., Vennin, P., Narducci, F., Merlot, B., Bresson, L., Farré, I., Salzet, M., Bertrand, O. F., Maillez, A., & Adenis, C. (2014) · ONCOLOGIE · doi:10.1007/s10269-014-2451-6 · Cited by 2
Preventive Strategies for Ovarian Cancer
Cortesi, L., Toss, A., & de, E. O. B. L. B. (2013) · InTech eBooks · doi:10.5772/54686 · Cited by 2
Agic, A., & Küpker, W. (2017) · Der Gynäkologe · doi:10.1007/s00129-017-4077-4 · Cited by 2
Pathogenesis of ovarian cancer: current perspectives
Chesang, J. (2017) · East African Medical Journal · Cited by 2
Михалева, Л. М., Игоревна, П. О., Безуглова, Т. В., Davydov, A. I., & Aliev, G. M. (2021) · CLINICAL AND EXPERIMENTAL MORPHOLOGY · doi:10.31088/cem2021.10.1.21-32 · Cited by 2
Endometriosis and ovarian cancer risk
de la Torre, J., Sánchez-Iglesias, J. L., Perez-Benavente, A., Gil‐Moreno, A., Dina, R. B., Uddin, M. Z., & Fatema, U. K. (2020) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2020.11.00515 · Cited by 2
Romanski, P. A., Bortoletto, P. E., & Lindheim, S. R. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.002 · Cited by 2
Pro-endometriosis macrophage release of IL-33 is key for endometriosis pain and lesion formationPreprint
Fattori, V., Rasquel-Oliveira, F. S., Ochoa, S., Graf, E., Bazzano, M. V., Aung, T., Vural, M., Kohl, C., Solano, M. E., da Silva, M. D. V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.20.683510 · Cited by 2
Reduction of the risk of ovarian endometriosis recurrence
Levakov, S. A., & Александровна, Г. Т. (2018) · Russian Journal of Human Reproduction · doi:10.17116/repro201824061132 · Cited by 1
Cybulska, P., Tseng, J. H., Zhou, Q. C., Iasonos, A. E., DeLair, D. F., Mueller, J. J., Roche, K. L., Abu‐Rustum, N. R., & Leitão, M. M. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26597 · Cited by 1
Acute Presentation of Large Size Clear Cell Ovarian Carcinoma as Double Torsed Ovarian Tumor
Bužinskienė, D., Rudaitis, V., & Misevičiūtė, K. (2022) · Medicina · doi:10.3390/medicina58010089 · Cited by 1
Management of Pelvic Pain, Dyspareunia, and Endometriosis
Chen, J. H. (2023) · Springer eBooks · doi:10.1007/978-3-031-14881-1_78 · Cited by 1
Qian, J., Peng, M., Li, Y., Liu, W., Zou, X., Chen, H., Zhou, S., Xiao, S., & Zhou, J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1380093 · Cited by 1
Campbell, R., Milford, K., Peyton‐Jones, B., & Hannemann, M. M. (2024) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12948 · Cited by 1
Ovarialkarzinom – Genetik und Prävention
Rhiem, K., Hauke, J., Tüchler, A., & Schmutzler, R. (2025) · Die Onkologie · doi:10.1007/s00761-025-01756-7 · Cited by 1
Zhang, H., Zhang, Y., Wu, Y. R., Lin, Y., Ding, J., Sun, N., & Deng, C. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c05667 · Cited by 1
Rethinking estrogen receptor β in EAOC: a synergistic modulator in a genomically informed landscape
Luo, L., Dai, W., Cao, N., & Ye, M. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-01990-6 · Cited by 1
Barriers and Facilitators Affecting the Care of Patients with Endometriosis: A Scoping Review
Bayrak, S., Allak, A., Neugebauer, T., Pardon, S., Yilmaz-Aslan, Y., Schiermeier, S., Kiessling, C., Schmiedl, S., Dockweiler, C., & Brzoska, P. (2026) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2765-4322 · Cited by 1
Endometriosis and ovarian cancer risk
Bogani, G., Moore, K. N., Ray-Coquard, I. L., Ceccaroni, M., Coleman, R. L., Fotopoulou, C., Mabrouk, M., Taylor, H. S., Roman, H., Ferrari, F. A., et al. (2026) · Gynecologic Oncology · doi:10.1016/j.ygyno.2026.05.004 · Cited by 1
Yang, H., Liu, S., Chen, X., Yin, C., Xiao, L., Xu, W., Lv, S., Xie, L., & 尹春华 (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1762444 · Cited by 1
ON THE RISKS OF MALIGNISATION OF OVARIAN ENDOMETRIOMAS
Gabidullina, R. I., MINNULLINA, F. F., AKHMETOVA, D. I., ZARIPOVA, A. S., ZIDIHANOVA, K. I., & ROOT, D. A. (2023) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2023.16(4).78-82 · Cited by 1
Current Science and Practice of Surgical and Nonsurgical Opportunities for Ovarian Cancer Prevention
MacArthur, E., & Stone, R. L. (2024) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000900 · Cited by 1
Comprehensive Review of Endometriosis Based on Imaging Findings: What Radiologists Need to Know
Kim, H. J., Lee, E. J., Hong, S. S., Hwang, J., Chang, Y., Nam, B. D., Jeong, J., & Bae, S. H. (2025) · Journal of the Korean Society of Radiology · doi:10.3348/jksr.2024.0104 · Cited by 1
Roychoudhury, S., & Buza, N. (2025) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2025-0309-ra · Cited by 1
Chung, Y. S., Kim, H.-R., Baek, J. K., Kim, H., Yun, B. H., Kim, M. D., Lee, Y. J., & Seo, S. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15051959 · Cited by 1
Wang, J., Li, W., Feng, J., & Wang, Z. H. (2026) · Stem Cells International · doi:10.1155/sci/7134066 · Cited by 1
Fitas, L. S., Pinto, P. V., & Bernardes, J. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103468 · Cited by 1
Ottander, U., Björk, E., Israelsson, P., & Mincheva‐Nilsson, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1885409 · Cited by 1
Wong, J. S. M., Tan, G. F., Chia, C. S., Selvarajan, S., & Teo, M. C. C. (2015) · American journal of cancer case reports · Cited by 1
Reproductive Factors and Risk of Ovarian Cancer
Schüler, S., Ponnath, M., Lattrich, C., & Ortmann, O. (2013) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0032-1328686 · Cited by 1
Histology of endometriosis-associated ovarian carcinomas
Stasienko, E., Wiśniewska, M., Kamecki, K., Skręt-Magierło, J. E., Opławski, M., Brożyna, A. A., Maleńczyk, M., Koper, K., & Roszkowski, K. (2015) · Ginekologia Onkologiczna/Current Gynecologic Oncology · doi:10.15557/cgo.2015.0010 · Cited by 1
Management of Pelvic Pain, Dyspareunia, and Endometriosis
Chen, J. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-17798-4_78 · Cited by 1
Maligne epitheliale Tumoren des Ovars
Petru, E., Moinfar, F., Lang, P., Winter, R., Tamussino, K. F., & Sehouli, J. (2014) · Springer eBooks · doi:10.1007/978-3-662-43469-7_7 · Cited by 1
Maligne epitheliale Tumoren des Ovars
Petru, E., Moinfar, F., Winter, R., Tamussino, K. F., & Sehouli, J. (2018) · Springer eBooks · doi:10.1007/978-3-662-57430-0_6 · Cited by 1
Küpker, W., & Agic, A. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-57636-6_35 · Cited by 1
Manning‐Geist, B. L., Gordhandas, S., Ramalingam, P., & Zivanovic, O. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-82938-0.00004-5 · Cited by 1
Overview of Ovarian Tumours: Pathogenesis and General Considerations
Vroobel, K. M. (2023) · Essentials of Diagnostic Gynecological Pathology. · doi:10.1007/978-3-031-39659-5_5 · Cited by 1
Yılmaz, S. (2024) · JOURNAL OF BIOTECHNOLOGY AND STRATEGIC HEALTH RESEARCH · doi:10.34084/bshr.1465417 · Cited by 1
Epigenetic Landscapes of Endometriosis: From Pathogenesis to Precision Medicine
Więcek, A., Bezubik, A., Kananovich, V., Pietrzyk, K., & Pietrucha, T. (2024) · Acta Universitatis Lodziensis Folia Biologica et Oecologica · doi:10.18778/1730-2366.18.13 · Cited by 1
Infertility and Risk of Ovarian Cancer in the Women’s Health Initiative
Harris, H. R., Lind, K. E., Fest, S. N., Thomson, C. A., Saquib, N., Shadyab, A. H., Schnatz, P. F., Robles‐Morales, R., Qi, L., Strickler, H. D., et al. (2025) · Cancer Causes & Control · doi:10.1007/s10552-025-01962-z · Cited by 1
Rectal Endometriosis-Associated Adenocarcinoma: A Rare Entity Demanding Clinical Vigilance
Huang, X.-H., Weng, Y.-C., & Lu, Y. (2025) · Cureus · doi:10.7759/cureus.78661 · Cited by 1
Transcription factor addictions: exploring the potential Achilles’ Heel of endometriosis
Yang, Y., Du, Y., Ma, X., Yuan, G., Li, G., Zhang, Q., & Zhou, S. (2025) · Science China Life Sciences · doi:10.1007/s11427-024-2832-8 · Cited by 1
Origins of Epithelial Ovarian Cancer
Dubeau, L., & Teixeira, J. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803741-6.00001-x · Cited by 1
Cytokine Networks in the Ovary
Orsi, N. M., Field, S. L., Baskind, N. E., Allen, K., & Cummings, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804214-4.00002-6 · Cited by 1
Physical Activity as a Risk Factor for Ovarian Cancer
Huang, T., & Tworoger, S. S. (2017) · Energy balance and cancer · doi:10.1007/978-3-319-63483-8_13 · Cited by 1
Ovarian Carcinoma Associated with Endometriosis
Yasuda, M., & Yano, M. (2018) · Springer eBooks · doi:10.1007/978-981-10-8606-9_5 · Cited by 1
Distribution of malignant neoplasms among patients with endometriosis: an epidemiological study
Байрамова, Н. Н., Protasova, A. E., Раскин, Г. А., Yarmolinskaya, M. I., Tsypurdeyeva, A. A., & Gavrilova, M. D. (2018) · Journal of obstetrics and women s diseases · doi:10.17816/jowd6765-12 · Cited by 1
Campos, A. G. B., Rodríguez, A. C., Perales, M. G., Serna-Vela, F. J., Elizalde, D. G. C., & Martínez, M. D. C. R. (2019) · Journal of Ovarian Research · doi:10.1186/s13048-019-0515-3 · Cited by 1
Sporadic Ovarian and Fallopian Tube Cancer in Postmenopausal Women
Pérez-López, F. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-13936-0_5 · Cited by 1
Modern concepts of ovarian cancer
Yakovtsova, I. I., Oliynyk, A. Y., Danyliuk, S. V., & Hryhorenko, V. (2019) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2019-23(1)-32 · Cited by 1
Prediction of ovarian endometriosis recurrence and its neoplastic transformation
Levakov, S. A., & Александровна, Г. Т. (2019) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20191904117 · Cited by 1
Urdzík, P., Rabajdová, M., Urban, P., Dudič, R., Komanický, V., & Mareková, M. (2019) · Spectroscopy Letters · doi:10.1080/00387010.2019.1671870 · Cited by 1
Modugno, F., Fu, Z., Jordan, S. J., AOCS Group, Chang‐Claude, J., Fortner, R. T., Goodman, M. T., Moysich, K. B., Schildkraut, J. M., Berchuck, A., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00682-9 · Cited by 1
Self-citationLinking oxidative stress and ovarian cancers
Amano, T., & Chano, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819547-5.00008-0 · Cited by 1
Spotlight on oncologic outcomes and prognostic factors of pure endometrioid ovarian carcinoma
Çakır, C., Korkmaz, V., Cömert, G. K., Yüksel, D., Kılıç, F., Kılıç, Ç., Türkmen, O., & Turan, T. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102105 · Cited by 1
Prifti, C. A., Kwolek, D. S., Growdon, W. B., & Palamara, K. (2020) · Springer eBooks · doi:10.1007/978-3-030-50695-7_15 · Cited by 1
Ovarian Cancer risk factors and Their Mechanism of Action
Adaranijo, M. J., & Bach, C. (2018) · European Journal of Engineering and Technology Research · doi:10.24018/ejeng.2018.3.2.617 · Cited by 1
Kukstas, C. (2017) · InnovAiT Education and inspiration for general practice · doi:10.1177/1755738017716189 · Cited by 1
Küpker, W., & Agic, A. (2019) · Springer Reference Medizin · doi:10.1007/978-3-662-55601-6_35-1 · Cited by 1
Endometriosis, the Silent Disease: Molecular Targets, Active Principles, and Drug Delivery Systems
Teworte, S., & Luciani, P. (2022) · Helvetica Chimica Acta · doi:10.1002/hlca.202200132 · Cited by 1
Molecular steps towards improving prognosis in ovarian cancer
Hjerpe, E. (2014) · Figshare · Cited by 1
Rolla, E. D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727650537.793557762 · Cited by 1
Endometriosis and Cancer: Is There an Association?
Vega, M. G., Soto, E., & Goldberg, J. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-17849-3_5
Initiation and progression of Müllerian duct derived malignancies
van der Horst, P. (2013)
Ovarian Cancer Epidemiology: Risk, Diagnosis, and Prognosis
Kurta, M. L. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Defining the roles of autophagy in ovarian carcinoma
Spowart, J. E. (2012) · UVic’s Research and Learning Repository (University of Victoria)
Endometriosis and ovarian cancer – Authors' reply
Pearce, C. L., & Berchuck, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70103-1
Self-citationHormone concentrations during pregnancy and maternal risk of epithelial ovarian cancer
Schöck, H. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Malignome auf dem Boden einer Endometriose
Ulrich, U. A., Drienko, E., Reichert, V. M., Wunschel, A., & NOACK, F. (2016) · Gynäkologische Endokrinologie · doi:10.1007/s10304-015-0043-1
Erkrankungsassoziierte Neoplasien möglich
Reichert, V. M., Wunschel, A., Müller, F., NOACK, F., Schmidt, D., & Ulrich, U. A. (2015) · gynäkologie + geburtshilfe · doi:10.1007/s15013-015-0691-1
Reproduktive Faktoren und das Ovarialkarzinomrisiko
Schüler, S., Ignatov, A., & Ortmann, O. (2013) · Frauenheilkunde up2date · doi:10.1055/s-0033-1346691
Takahashi, H., Kajita, S., Tazo, Y., Iwase, H., Matsumoto, T., Hashimura, M., & Saegusa, M. (2016) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2016.02.001
Precursors of Low-Grade Serous Adenocarcinoma of the Ovary: Pathology and Molecular Pathways
Lawrenson, K., & Mhawech-Fauceglia, P. Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-22509-8_2
Precancerous Lesions of Ovarian Clear Cell and Endometrioid Carcinomas
Roma, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-22509-8_3
CHOCOLATE CYST – A COMPLEX OVARIAN ENDOMETRIOMA
Saha, B. (2014) · International Journal of Pharma and Bio Sciences
Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or Peritoneum
Gershenson, D. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-32110-3_13
The role of H1 linker histone variants in ovarian cancer
Medrzycki, M. (2013) · SMARTech Repository (Georgia Institute of Technology)
Консенсус по ведению эндометриоза
Johnson, N. P., & Hummelshøj, L. (2013) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy · doi:10.18370/2309-4117.2013.12.66-88
Stewart, L. M. (2013) · UWA Profiles and Research Repository (UWA)
Endometriosis Is Associated with Risk for Ovarian Carcinoma
Rebar, R. W. (2012) · Journal watch · doi:10.1056/wh201203150000002
Ovarian Cancer Following Use of Clomiphene and Gonadotropin in Assisted Reproduction
Makar, A. P. (2017) · Cambridge University Press eBooks · doi:10.1017/9781107295391.001
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
